Skip to main content
. 2014 Sep 5;3(3):997–1017. doi: 10.3390/jcm3030997

Table 1.

Applications of iPSCs in liver diseases.

Applications Diseases iPSCs from Donor References
Regenerative Medicine fulminant hepatic failure mouse normal iPSCs [10]
liver regeneration mouse normal iPSCs [11]
liver fibrosis mouse normal iPSCs [12]
chronic liver disease mouse normal iPSCs [13]
BAL liver failure human normal iPSCs [14]
Gene Therapy A1AT deficiency A1AT deficiency patient iPSCs [15]
WD WD patient [16]
Liver Diseases Model HBV, HCV human normal iPSCs [17]
HCV human normal iPSCs [18,19]
A1AT deficiency GSD, FH, Crigler-Najjar syndrome, hereditary tyrosinemia patients iPSCs [5,20]
Drug Discovery and Hepatoxicity Screening Normal liver patients iPSCs or human normal iPSCs [5,21,22,23,24,25]